The Discounted Cash Flow (DCF) valuation of United Therapeutics Corp (UTHR) is 464.88 USD. With the latest stock price at 405.02 USD, the upside of United Therapeutics Corp based on DCF is 14.8%.
Based on the latest price of 405.02 USD and our DCF valuation, United Therapeutics Corp (UTHR) is a buy. buying UTHR stocks now will result in a potential gain of 14.8%.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 9.3% | 8.2% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 368.16 - 657.17 | 464.88 |
| Upside | -9.1% - 62.3% | 14.8% |